Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.22 USD | -0.92% | -3.87% | +16.61% |
05-14 | Transcript : Cellectar Biosciences, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Cellectar Biosciences, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+16.61% | 117M | |
+36.93% | 723B | |
+32.22% | 598B | |
-2.10% | 364B | |
+20.30% | 331B | |
+3.70% | 288B | |
+16.60% | 244B | |
+9.77% | 210B | |
-5.15% | 208B | |
+8.57% | 169B |
- Stock Market
- Equities
- CLRB Stock
- News Cellectar Biosciences, Inc.
- Cellectar Biosciences, Florida Cancer Specialists & Research Institute to Collaborate on Lymphoma Research